Results 111 to 120 of about 27,792 (251)
Eric Rytkin,1 Karin B Mirzaev,1 Elena A Grishina,1 Valeriy V Smirnov,2 Kristina A Ryzhikova,1 Zhannet A Sozaeva,1 Michael Iu Giliarov,2 Denis A Andreev,2 Dmitriy A Sychev1 1Russian Medical Academy of Continuous Professional Education, 2I.M.
Rytkin E +8 more
core
Genomic Medicine Sweden: Advancing precision medicine at the national level
Abstract High‐throughput sequencing has transformed clinical diagnostics of rare diseases (RD), cancer and infectious diseases by enabling the identification of disease‐causing genetic alterations and facilitating individualised treatment and care.
Anders Edsjö +58 more
wiley +1 more source
CYP2C19 polymorphisms in drug metabolism and response
Individuals vary widely in their response to drug treatment. After receiving doses of a drug that are recommended based on a population average, some patients could have an insufficient response, whereas others may experience adverse effects. Of the many
Ming Chang (18637489)
core +1 more source
CYP2C19 Polymorphism in Childhood Hematological Malignancy [PDF]
Cytochrome P450 2C19 (CYP2C19) participates in the metabolism of many clinically important drugs and many xenobiotic compounds. Genetic polymorphisms of the CYP2C19 gene are described to have possible effect on drug treatment and increasing ...
Abu_eid, Sameer Ibrahim
core
Sixteen indazole–sulfonamide hybrids exhibit species‐dependent antibacterial activity against E. coli and S. aureus, with the lead compound displaying an eightfold lower MIC than sulfathiazole against E. coli. Molecular docking against wild‐type and Sul1‐resistant dihydropteroate synthase identifies a candidate retaining binding affinity toward the ...
Romaisaa Boudza +8 more
wiley +1 more source
Study of CYP2C19 gene polymorphisms in children with pharmacoresistant epilepsy
Проведено фармакогенетичне дослідження 83 дітей з фармакорезистентною епілепсією віком від 11 місяців до 18 років. За допомогою алель-специфічної полімеразної ланцюгової реакції (ПЛР) визначено поліморфізм гена CYP2C19 (CYP2C19*1 CYP2C19*2).
Танцура, Євген Олександрович +3 more
core +1 more source
Phytochemical profiling was determined via HPLC and GC–MS analysis. In HPLC analysis, five compounds were identified, while five compounds were identified through GC–MS. The plant extract exhibited good antioxidant efficacy in the DPPH assay, highlighting its capacity to neutralize free radicals. The extract has IC5₀ value of 123.8 µg/mL, while that of
Muhammad Zahoor +5 more
wiley +1 more source
Himalayan Strobilanthes species: phytochemical profiling, bioactivities, and In silico Studies. ABSTRACT Five Strobilanthes species indigenous to the Kumaun Himalayan region of Uttarakhand, India, have been historically employed in traditional medicine to treat bacterial infections, inflammatory conditions, and respiratory ailments, but remain largely ...
Sakshi Negi +12 more
wiley +1 more source
Distribution of genotypes of CYP2C19.
Distribution of genotypes of CYP2C19.
Yi-Tong Ma (317802) +8 more
core +1 more source
Wenhao Chen,1 Yuanliang Liu,2 Xunwei Deng,3 Bin Li,1 Hao Wang,1 Guoliang Wei,1 Kehui Chen,1 Shen Wang1 1Center for Cardiovascular Diseases, Meizhou People’s Hospital, Meizhou, People’s Republic of China; 2Department of Computer Tomography, Meizhou People’
Liu Y +7 more
core

